1.4 percent had dual reported recovery and problem-resolving status, 2.5 percent had problem resolution only, 2.9 percent had recovery only

Authors say one explanation for the trend is untreated withdrawal with more severe opioid use disorder

At pandemic outset, significant decreases in buprenorphine prescription fills seen for Black, Hispanic patients, but not White patients

<p>8-mg dose of naloxone hydrochloride nasal spray now approved with 2-mg and 4-mg doses</p>